Results 231 to 240 of about 116,135 (274)
Some of the next articles are maybe not open access.
Drug design and delivery, 1989
The electrostatic molecular potential (EMP) of model compounds (isoproterenol and four of its analogs) with agonist activity on the beta-adrenergic receptor was investigated, at the SCF-MO ab initio level. A method was developed to calculate the drug-receptor interaction energy (delta E) for these compounds, and the EMP and delta E values were compared
B, Macchia, A, Martinelli
openaire +1 more source
The electrostatic molecular potential (EMP) of model compounds (isoproterenol and four of its analogs) with agonist activity on the beta-adrenergic receptor was investigated, at the SCF-MO ab initio level. A method was developed to calculate the drug-receptor interaction energy (delta E) for these compounds, and the EMP and delta E values were compared
B, Macchia, A, Martinelli
openaire +1 more source
Beta agonists in livestock feed: status, health concerns, and international trade.
Journal of Animal Science, 2014T. Centner, J. Alvey, A. Stelzleni
semanticscholar +1 more source
Beta-2 adrenergic agonists: focus on safety and benefits versus risks.
Current opinion in pharmacology (Print), 2010V. Ortega, S. Peters
semanticscholar +1 more source
Journal of Molecular and Cellular Cardiology, 1986
Richard W. Tsien +5 more
semanticscholar +1 more source
Richard W. Tsien +5 more
semanticscholar +1 more source
BJOG : an international journal of obstetrics and gynaecology, 2001
To compare the effectiveness and safety of the oxytocin antagonist atosiban with conventional beta-adrenergic agonist (beta-agonist) therapy in the treatment of preterm labour.Three multinational, multicentre, double-blind, randomised, controlled trials. Setting Hospitals in Australia, Canada, Czech Republic, Denmark, France, Israel, Sweden, and the UK.
openaire +1 more source
To compare the effectiveness and safety of the oxytocin antagonist atosiban with conventional beta-adrenergic agonist (beta-agonist) therapy in the treatment of preterm labour.Three multinational, multicentre, double-blind, randomised, controlled trials. Setting Hospitals in Australia, Canada, Czech Republic, Denmark, France, Israel, Sweden, and the UK.
openaire +1 more source
Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 2022
Hua Kuang, Chuanlai Xu, Xinxin Xu
exaly
Hua Kuang, Chuanlai Xu, Xinxin Xu
exaly

